Catalent and Stevanato Expand Partnership for the Accelerated Delivery of COVID-19 Solutions

October 27, 2020
BioPharm International Editors

Under the partnership, Catalent has ordered visual inspection machines from Stevanato Group to install at its Bloomington, IN and Anagni, Italy facilities to support customer programs.

Catalent and Stevanato Group, an producer of glass primary packaging and integrated systems headquartered in Italy, announced on Oct. 27, 2020 that they are expanding their longstanding collaboration to accelerate the delivery of advanced visual inspection systems to help with potential solutions for the COVID-19 pandemic.

Under the partnership, Catalent has ordered Plus 400 LKD automatic and PWL semi-automatic visual inspection machines from Stevanato Group to install at its Bloomington, IN, and Anagni, Italy facilities to support customer programs, a Stevanato press release said. Stevanato will accelerate the delivery of the equipment by several months to meet the demands of the pandemic.

“Catalent appreciates Stevanato Group’s commitment to delivering these vital inspection machines to our sites ahead of schedule,” said Dominick Marino, vice-president of Global Procurement at Catalent, in the press release. “This added capability will increase the speed in which we package and supply important medicines for our customers and patients.”

“We understand what is at stake, and our engineers are committed to delivering high-performance inspection machines ahead of schedule to meet Catalent’s needs and expectations,” added Raffaele Pace, engineering vice-president of Operations, Stevanato Group, in the press release.

Source: Stevanato Group